Programmed cell death protein 1 (PD-1)-inhibition in hepatocellular carcinoma (HCC): a single center experience.
CONCLUSIONS: Despite numerous pretreatments, PD-1 inhibition was well tolerated and showed clinical benefit in patients with heavily pretreated HCC.
PMID: 32692941 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Allergy & Immunology | Cancer & Oncology | Carcinoma | Clinical Trials | Gastroenterology | Germany Health | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer | PET Scan | Study